Skip to main content
. 2022 Oct 27;7(2):196–204. doi: 10.1182/bloodadvances.2022007791

Figure 2.

Figure 2.

Kaplan-Meier curves for survival outcomes, starting from day 1 of the DI course, for patients who received <4 (blue) or ≥4 (red) doses of PEG-asparaginase. (A) OS, (B) EFS.